Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis

British Journal of Rheumatology

Volumn 37, Issue 9, 1998, Pages 946-951

  Dequeker, J ^g   Hawkey, C ^h   Kahan, A ^a   Steinbruck K ^h   Alegre, C ^b   Baumelou, E ^c   Begaud B ^d   Isomaki H ^e   Littlejohn, G ^h   Mau, J ^f   Papazoglou, S ^h  

^a Institut Cochin   (France)

^b Hosp de Enferm Reumáticas   (Spain)

^c FOCH HOSPITAL   (France)

^d HÔPITAL PELLEGRIN   (France)

^e RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h NONE

Author keywords

Cyclooxygenase; Gastrointestinal tolerability; Meloxicam; Osteoarthritis; Perforations; Piroxicam; Ulcerations or bleedings

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; PIROXICAM;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPEPSIA; ENZYME INHIBITION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STOMACH HEMORRHAGE; STOMACH PERFORATION; STOMACH ULCER; VOMITING;

EID: 0031696493     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.9.946     Document Type: Article

References (14)

1. Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. Br J Rheumatol 1998;37:937-45.
2. Brogden RN, Heel RC, Speight TM, Avery GS. Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy. Drugs 1984;28:292-323.
3. Henry D, Lim LYL, Rodriguez LAG et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996;312:1563-6.
4. Schattenkirchner M. Meloxicam: a selective COX-2 inhibitor non-steroidal anti-inflammatory drug. Expert Opin Invest Drugs 1997;6:321-34.
5. Ghozlan PR, Bernhardt M, Velicitat P, Bluhmki E. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis. Br J Rheumatol 1996;35(suppl. 1):51-5.
6. Lindén B, Distel M, Bluhmki E. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip. Br J Rheumatol 1996;35(suppl. 1):35-8.
7. Hosie J, Distel M, Bluhmki E. Efficacy and tolerability of meloxicam versus piroxicam in patients with osteoarthritis of the hip or knee: a six-month double-blind study. Clin Drug Invest 1997;13:175-84.
8. Bellamy N, Carette S, Ford PM et al. Osteoarthritis antirheumatic drug trials III. Setting the delta for clinical trials - results of a consensus development (Delphi) exercise. J Rheumatol 1992;19:451-7.
9. Chalmers TC, Berrier J, Hewitt P et al. Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy. Aliment Pharmacol Ther 1988;2:9-26.
10. Distel M, Mueller C, Bluhmki E, Fries J. Safety of meloxicam: A global analysis of clinical trials. Br J Rheumatol 1996;35(suppl. 1):68-77.
11. Frölich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase enzymes. Trends Pharmacol Sci 1997;18:30-4.
12. Engelhardt G, Bögel R, Schnitzler C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism. In vitro findings - part I. Biochem Pharmacol 1996; 51:21-8.
13. Meade EA, Smith WL, DeWitt DC. Differential inhibition of prostaglandin endoperoxide synthase (cyclo-oxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-4.
14. Mitchell JA, Akarasereemont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-7.